Related Experiment Video

Updated: Jun 16, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

The optimal neoadjuvant chemotherapy regime for muscle-invasive bladder cancer: still an open question?

Andreas Carus1, Karin Holmsten2,3, Helle Pappot4

  • 1Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.

Acta Oncologica (Stockholm, Sweden)
|December 9, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K

Related Experiment Videos

Last Updated: Jun 16, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Evolving person-focused cancer care: the multifaceted benefits of electronic PRO integration and radiation therapist-led follow-up in radiotherapy.

Technical innovations & patient support in radiation oncology·2026

[Upper tract urothelial carcinoma - regional differences observed in several quality indicators].

Lakartidningen·2026

Relations in young adults with cancer: acknowledging partners and friends as caregivers-a Danish national study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Exploring the use of a youth specific screening tool in hematological cancer care: perspectives from young adult patients and healthcare professionals.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Change in skeletal muscle mass during systemic cancer treatment: a systematic review and meta-analysis.

Acta oncologica (Stockholm, Sweden)·2026

Update of the EORTC Health-related Quality of Life Modules for Bladder Cancer: Phase 1-2 of the Development Process.

European urology oncology·2026

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Acta oncologica (Stockholm, Sweden)·2026

Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature.

Acta oncologica (Stockholm, Sweden)·2026

Interpreter use in Nordic paediatric oncology care - a multicentre cross-sectional study.

Acta oncologica (Stockholm, Sweden)·2026

Tolerability and adherence to adjuvant abemaciclib in hormone receptor-positive, HER2-negative, node-positive high-risk early breast cancer: a real-world study.

Acta oncologica (Stockholm, Sweden)·2026

Prognostic significance of isolated tumor cells and nodal tumor burden in endometrial cancer: a population-based cohort study.

Acta oncologica (Stockholm, Sweden)·2026

Improving cervical cancer screening uptake through theory-informed education: a comprehensive systematic review and meta-analysis.

Acta oncologica (Stockholm, Sweden)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us